Company Filing History:
Years Active: 1977
Title: **Innovations by Jean Schwartz: Advancements in Pharmaceutical Compounds**
Introduction
Jean Schwartz, an accomplished inventor based in Strasbourg, France, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Schwartz has demonstrated his expertise in developing innovative compounds aimed at addressing critical health issues.
Latest Patents
Schwartz's latest patents include a method for creating O-aminoalkyl oximes and a formulation for the treatment of hypertension. The O-aminoalkyl oximes patent involves compounds represented by a specific formula, where R¹ can be selected from a variety of groups including phenyl and naphthyl, along with various alkyl, alkoxy, halogen, nitro, amino, and cyano substituents. This compound has potential applications in various therapeutic areas.
The second patent focuses on guanidines of a formula, particularly those where R and R' can be hydrogen or methyl. These compounds, including their pharmaceutically acceptable acid addition salts, are noted for their hypotensive effects, making them valuable in the management of hypertension.
Career Highlights
Jean Schwartz is currently associated with Seperic, a company that specializes in developing pharmaceutical innovations. His work has contributed to advancements in medicinal chemistry and the treatment of cardiovascular conditions.
Collaborations
In his pursuits, Schwartz collaborates closely with Camille G. Wermuth, a fellow expert in the field. Their teamwork has fostered a creative environment that enhances the innovation process, enabling the development of new healthcare solutions.
Conclusion
Through his innovative patents and collaborations, Jean Schwartz underscores the impact of dedicated inventors in advancing healthcare technologies. His work represents a commitment to improving patient outcomes and echoes the importance of ongoing research and development in the pharmaceutical industry.